Dataset | Pathology | Total | ||
---|---|---|---|---|
Dataset A | Normal | NMLs | ||
Training Set | Patients, n, % | 481 | 172 | 653 |
60% | 40% | |||
Images, n, % | 702 | 608 | 1310 | |
54% | 46% | |||
Validation Set | Patients, n, % | 66 | 31 | 97 |
68% | 32% | |||
Images, n, % | 100 | 88 | 188 | |
53% | 47% | |||
Testing Set | Patients, n, % | 49 | 25 | 74 |
66% | 34% | |||
Images, n, % | 201 | 174 | 375 | |
54% | 46% | |||
Dataset B | Benign MLs | Malignant MLs | ||
Training Set | Patients, n, % | 2728 | 1249 | 3977 |
69% | 31% | |||
Images, n, % | 7260 | 3359 | 10,619 | |
68% | 32% | |||
Validation Set | Patients, n, % | 352 | 158 | 510 |
69% | 31% | |||
Images, n, % | 863 | 426 | 1289 | |
67% | 33% | |||
Internal Testing Set | Patients, n, % | 338 | 163 | 501 |
67% | 33% | |||
Images, n, % | 862 | 477 | 1339 | |
64% | 36% | |||
Dataset C | Benign NMLs | Malignant NMLs | ||
External Testing Set | Patients, n, % | 135 | 93 | 228 |
59% | 41% | |||
Images, n, % | 505 | 365 | 870 | |
58% | 42% |